Novartis Says Adverse Gleevec Ruling Would Impact Outlook For India
This article was originally published in PharmAsia News
Executive Summary
As India’s Supreme Court prepares to deliver a landmark verdict next week on the patentability of Gleevec, Novartis prepares for stormy weather.